Paul D. Burgess - Title: Chief Business Development and Strategic Operations Officer at Cerevel Therapeutics Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Title: Chief Business Development and Strategic Operations Officer
Stock Symbol
CERE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Paul D. Burgess - trading volume in the past year for Cerevel Therapeutics Holdings, Inc.

Holdings reported by Paul D. Burgess for Cerevel Therapeutics Holdings, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 81,065 $3.42 M $42.24 Jan 19, 2024 Direct Common Stock
Common Stock 45,727 $1.93 M $42.24 Dec 19, 2023 Direct
Stock Option (Right to Buy) 95,931 Jul 3, 2023 Direct Common Stock

Transactions reported by Paul D. Burgess for Cerevel Therapeutics Holdings, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership